Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence Ciro Celsa; Caterina Stornello; Paolo Giuffrida; Carmelo Marco Giacchetto; Mauro Grova; Gabriele Rancatore; Concetta Pitrone; Vito Di Marco; Calogero Cammà; Giuseppe Cabibbo;

Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients Kanako Kikukawa; Sawako Uchida-Kobayashi; Akihiro Tamori; Kanako Yoshida; Kohei Kotani; Hiroyuki Motoyama; Ritsuzo Kozuka; Atsushi Hagihara; Hideki Fujii; Hiroyasu Morikawa; Masaru Enomoto; Yoshiki Murakami; Norifumi Kawada;

Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies Jui-Hsiang Hung; Chiao-Feng Teng; Hsu-chin Hung; Yi-Lin Chen; Pin-Jun Chen; Chung-Liang Ho; Cheng-Hsiang Chuang; Wenya Huang;